
Phathom Pharmaceuticals Investor Relations Material
Latest events

Q1 2025
Phathom Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Phathom Pharmaceuticals Inc
Access all reports
Phathom Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal diseases. The company’s research is centered around novel therapies that address acid-related disorders, such as gastroesophageal reflux disease (GERD) and related conditions. Phathom aims to provide new treatment options that improve the management of these chronic conditions, particularly in areas where current therapies may be inadequate. The company is headquartered in Florham Park, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Phathom Pharmaceuticals Inc


Corporate Presentation
Phathom Pharmaceuticals Inc


Corporate Presentation
Phathom Pharmaceuticals Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
PHAT
Country
🇺🇸 United States